Alzheimer's Disease Trial, Not Yet Recruiting NCT07526480 Sponsor: Thomas Jefferson University Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Not Yet Recruiting

NCT07526480
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have not previously been diagnosed with mild cognitive impairment (MCI) or Alzheimer's disease.
  • People who have a visit with their primary care doctor scheduled within the next 4 to 6 weeks.
  • People who feel they have been experiencing problems with their memory or thinking.
  • People who score 26 or higher on a cognitive screening test done over the phone called the TICS (Telephone Interview for Cognitive Status).

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose medical records or previous cognitive testing show a diagnosis of mild cognitive impairment or Alzheimer's disease, or who have been taking medications used to treat Alzheimer's disease.
  • People who score 11 or below on the TICS phone cognitive screening test.
  • People who are not able to give their own consent to participate in the trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 10 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Barry Rovner, MD, Thomas Jefferson University

Phone: 267-872-1302

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Thomas Jefferson University
Registry
ClinicalTrials.gov
Start date
4 May 2026
Est. completion
3 May 2027

Primary endpoints

Incident cognitive diagnoses.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 10 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov